Application 218391
- Type
- ANDA
- Sponsor
- XIROMED
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | PROGESTERONE | PROGESTERONE | INSERT;VAGINAL | 100MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A218391-001 | PROGESTERONE | PROGESTERONE | 100MG | INSERT / VAGINAL | AB | 2025-09-19 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A218391-001 | AB |
Orange Book exclusivity#
| Application-product | Exclusivity code | Expiration |
|---|---|---|
| A218391-001 | CGT | 2026-03-22 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | A218391-001 | PROGESTERONE | 100MG | INSERT / VAGINAL | AB | 2025-09-19 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | A218391-001 | PROGESTERONE | 100MG | INSERT / VAGINAL | AB | 2025-09-19 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A218391-001 | PROGESTERONE | 100MG | INSERT / VAGINAL | AB | 2025-09-19 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A218391-001 | PROGESTERONE | 100MG | INSERT / VAGINAL | AB | 2025-09-19 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A218391-001 | PROGESTERONE | 100MG | INSERT / VAGINAL | AB | 2025-09-19 | 31067a03dcf5… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218391-001 | PROGESTERONE | 100MG | INSERT / VAGINAL | AB | 2025-09-19 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | A218391-001 | AB | 1 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | A218391-001 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A218391-001 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A218391-001 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A218391-001 | AB | 1 | 31067a03dcf5… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218391-001 | AB | 1 | a50c72e98297… |
Observed Orange Book exclusivity history#
| Captured | Edition | Application-product | Exclusivity code | Expiration | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | A218391-001 | CGT | 2026-03-22 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | A218391-001 | CGT | 2026-03-22 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A218391-001 | CGT | 2026-03-22 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A218391-001 | CGT | 2026-03-22 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A218391-001 | CGT | 2026-03-22 | 31067a03dcf5… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218391-001 | CGT | 2026-03-22 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Progesterone | PROGESTERONE | Asclemed USA, Inc. | 19716042-8025-43a3-b26d-e0fd7d2587eb | 2022-10-12 | Boxed warning, Warnings, Adverse reactions | Progesterone PROGESTERONE |
| Progesterone | PROGESTERONE | Asclemed USA, Inc. | efd6a8d8-c023-4d9f-b574-b14dc945203d | 2022-10-12 | Boxed warning, Warnings, Adverse reactions | Progesterone PROGESTERONE |
| Progesterone | PROGESTERONE | Asclemed USA, Inc. | 4a741977-1dbb-41e7-a560-9ac02936f8b1 | 2022-09-15 | Boxed warning, Warnings, Adverse reactions | Progesterone PROGESTERONE |
| Progesterone | PROGESTERONE | Proficient Rx LP | e1546b35-cfa8-4808-9652-db1ba675a4e3 | 2022-08-01 | Boxed warning, Warnings, Adverse reactions | Progesterone PROGESTERONE |
| Progesterone | PROGESTERONE | Proficient Rx LP | 73e65b35-2266-48a3-98f8-521446a55c22 | 2022-04-01 | Boxed warning, Warnings, Adverse reactions | Progesterone PROGESTERONE |
| PROGESTERONE | PROGESTERONE | Bionpharma Inc. | 3acad9b0-7ec6-4d5e-9852-32ffadbbed6d | 2018-03-11 | Boxed warning, Warnings, Adverse reactions | PROGESTERONE PROGESTERONE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents#
| Document | Submission type | Date |
|---|---|---|
| 83419 | ORIG | 2025-09-23 |